Group Leader
Matilde Lleonart Pajarin
Principal Investigator (PI)
Juan Lorente Guerrero, Sergi Benavente Norza, Josep Castellvi Vives, Jordi Temprana Salvador
Researchers
Yoelsis García Mayea
PhD Students
Cristina Mir Pérez, Almudena Sánchez García, Marina Bataller Fernandez
Nursing and Technical Staff
Maria Isabel Rodriguez Hernández
13
PUBLICATIONS
101
IMPACT FACTOR
7.75
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Cristina Mir, Yoelsis Garcia-Mayea, Laia Garcia, Pol Herrero, Nuria Canela, Rocío Tabernero, Juan Lorente, Josep Castellvi, Eva Allonca, Juana García-Pedrero, Juan Pablo Rodrigo, Ángel Carracedo, and Matilde Esther LLeonart
SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
Cancers (Basel). 2021 Oct; 13(19): 4952.
DOI: 10.3390/cancers13194952
IF: 6.639
Takumi Mikawa, Eri Shibata, Midori Shimada, Ken Ito, Tomiko Ito, Hiroaki Kanda, Keiyo Takubo, Atsuyoshi Shimada, Matilde E. Lleonart, Nobuya Inagaki, Masayuki Yokode, Hiroshi Kondoh
Characterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis
PLoS One. 2021; 16(4): e0250856.
DOI: 10.1371/journal.pone.0250856
IF: 3.24
Alberto Indacochea, Santiago Guerrero, Macarena Ureña, Ferrán Araujo, Olga Coll, Matilde E. LLeonart, Fátima Gebauer
Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels
RNA. 2021 Feb; 27(2): 190–201.
DOI: 10.1261/rna.076422.120
IF: 4.39
Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli, Steffen Abel, Hagai Abeliovich, Marie H. Abildgaard,...LLeonart ME...Chun-Kit Tong
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Autophagy. 2021; 17(1): 1–382.
DOI: 10.1080/15548627.2020.1797280
IF: 16.016
Hiroshi Kondoh, Josep Castellvi, Matilde Esther LLeonart
Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
Front Oncol. 2021; 11: 671222.
DOI: 10.3389/fonc.2021.671222
IF: 4.416
Nuevas aproximaciones terapéuticas en cáncer de cabeza y cuello.
Principal Investigator: Matilde E. LLeonart
Agency: Ministerio de Sanidad
Funding: 180,000 €
Period: 2021-2024
Novel Therapeutic approaches against COVID-19
Principal Investigator: Matilde E. LLeonart
Agency: Fundació La Marató TV3
Funding: 250,000 €
Period: 2022-2025
Tumors of low prevalence
Principal Investigator: Santiago Ramón y Cajal
Agency: Ministerio de Sanidad
Funding: -
Period: 2017-2021
Oncology
- Signalling and New Therapeutic Targets
- Drug Delivery and Targeting
- Biomedical Research in Digestive Tract Tumors
- Biomedical Research in Melanoma
- Translational Research in Child and Adolescent Cancer
- Biomedical Research in Cancer Stem Cells
- Translational Molecular Pathology
- Biomedical research in Urology
- Biomedical Research in Gynecology